Chugai Pharmaceutical Co Ltd - Price Analysis Snapshot

This Report features up to a ten-year record of the equity Price history for Chugai Pharmaceutical Co Ltd. Tabular results include the High, Low and Closing price for the quarter. There is also a calculation of percentage change in price for both Quarterly and Annual periods. Price values are adjusted for stock splits and dividends.

Chugai Pharmaceutical Co Ltd. The Group's principal activity is to manufacture pharmaceutical products. The products include prescription medicines for central nervous, cardiovascular, respiratory, gastrointestinal and metabolic systems, hormones and diagnostic products and OTC drugs. The operations are carried out through the following divisions: Pharmaceuticals and Other operations. The major products are epogin, alfarol, neutrogin, sigmart , suvenyl, oxarol, rocephin, renagel and rythmodan.

Not the Report you are looking for? Click here for more browsing options.

view sample Single Report

view sample All Basic Reports

Layout and Content of a Typical Report